Electrical devices (e.g., cardiac rhythm management and neurostimulation devices) for contact with tissue are used in combination with an anti-scarring agent (e.g., a cell cycle inhibitor) in order to inhibit scarring that may otherwise occur when the devices are implanted within an animal.

 
Web www.patentalert.com

< Benzimidazole derivative and use thereof

< Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

> Ammonolysis process for the preparation of intermediates for DPP IV inhibitors

> Inherently radiopaque bioresorbable polymers for multiple uses

~ 00203